Plasma pharmacokinetic parameters for MPO after intravenous or subcutaneous administration to normal rhesus monkeys
| Pharmacokinetic Parameters . | Rhesus . |
|---|---|
| Intravenous* | |
| Dose (μg/kg) | 10 |
| Half-lives (h) | |
| First | 0.533 ± 0.051 |
| Second | 25.3 ± 14.0 |
| Clearance (mL/min/kg) | 0.415 ± 0.070 |
| VC (L/kg)† | 0.0220 ± 0.0026 |
| VSS (L/kg)† | 0.0706 ± 0.0481 |
| Subcutaneous* | |
| Dose (μg/kg) | 30 |
| CMAX (ng/mL) | 97.4 ± 29.1 |
| TMAX (h) | 3.3 ± 1.3 |
| AUC ([ng/mL]h)‡ | 806 ± 368 |
| Bioavailability (%) | 62.5 |
| Pharmacokinetic Parameters . | Rhesus . |
|---|---|
| Intravenous* | |
| Dose (μg/kg) | 10 |
| Half-lives (h) | |
| First | 0.533 ± 0.051 |
| Second | 25.3 ± 14.0 |
| Clearance (mL/min/kg) | 0.415 ± 0.070 |
| VC (L/kg)† | 0.0220 ± 0.0026 |
| VSS (L/kg)† | 0.0706 ± 0.0481 |
| Subcutaneous* | |
| Dose (μg/kg) | 30 |
| CMAX (ng/mL) | 97.4 ± 29.1 |
| TMAX (h) | 3.3 ± 1.3 |
| AUC ([ng/mL]h)‡ | 806 ± 368 |
| Bioavailability (%) | 62.5 |